Dr. Hakima Amri is a professor at Georgetown University School of Medicine in the Department of Biochemistry and Cellular and Molecular Biology and the Division of Integrative Physiology. She holds a Master of Science degree in Reproductive Physiology and a PhD in Steroid Biochemistry from Pierre and Marie Curie University-Sorbonne, Paris, France. She then moved to the United States, where she joined the Georgetown University Faculty. Dr. Amri’s research focus is on understanding the action mechanism of disease processes using comprehensive systems biology approaches. She investigates cancer biomarkers and bio-signature identification using big data. Her project is enhanced by the novel analytical approach she recently developed in collaboration with her colleagues. She uses this novel method to translate cancer omics, from genomics, proteomics, and metabolomics high-throughput data, into molecular signatures that are then presented in a multidimensional and dynamic model best suited for precision medicine. Dr. Amri is currently working on translating Phylomics® (http://phylomics.com) into a cost-effective and noninvasive diagnostic tool. Her work is supported by a recently granted patent by the US Patents Office. Dr. Amri has taught a significant number of students in classroom and laboratory settings, spanning undergraduate, graduate, doctoral, and postdoctoral levels. She received funding from both government and private sectors. Her scholarly activities are marked by her published work in peer-reviewed journals, presentations at national and international conferences, and authorship of a book on Avicenna’s medicine, several book chapters, and reviews.